These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Isotretinoin: dose, duration and relapse. What does 30 years of usage tell us? Rademaker M. Australas J Dermatol; 2013 Aug; 54(3):157-62. PubMed ID: 23013115 [Abstract] [Full Text] [Related]
13. Aspects of roaccutane prescription in South Africa. Smart AJ, Walters L. S Afr Med J; 1994 Aug; 84(8 Pt 1):497-502. PubMed ID: 7825086 [Abstract] [Full Text] [Related]
14. An expert view on the treatment of acne with systemic antibiotics and/or oral isotretinoin in the light of the new European recommendations. Dréno B, Bettoli V, Ochsendorf F, Perez-Lopez M, Mobacken H, Degreef H, Layton A. Eur J Dermatol; 2006 Aug; 16(5):565-71. PubMed ID: 17101480 [Abstract] [Full Text] [Related]
15. Comparison of the efficacies of intermittent and continuous low-dose isotretinoin regimens in the treatment of moderate acne vulgaris. Boyraz N, Mustak PK. Int J Dermatol; 2013 Oct; 52(10):1265-7. PubMed ID: 23675954 [Abstract] [Full Text] [Related]